Hyppää sisältöön
    • Suomeksi
    • In English
Trepo
  • Suomeksi
  • In English
  • Kirjaudu
Näytä viite 
  •   Etusivu
  • Trepo
  • TUNICRIS-julkaisut
  • Näytä viite
  •   Etusivu
  • Trepo
  • TUNICRIS-julkaisut
  • Näytä viite
JavaScript is disabled for your browser. Some features of this site may not work without it.

Prevalence and risk factors of musculoskeletal symptoms among treated coeliac disease patients

Tillqvist, Saara; Paavola, Saana; Pasternack, Camilla; Huhtala, Heini; Salmi, Teea; Kurppa, Kalle; Kaukinen, Katri; Laurikka, Pilvi (2025)

 
Avaa tiedosto
Prevalence_and_risk_factors_of_musculoskeletal_symptoms_among_treated_coeliac_disease_patients.pdf (1.035Mt)
Lataukset: 



Tillqvist, Saara
Paavola, Saana
Pasternack, Camilla
Huhtala, Heini
Salmi, Teea
Kurppa, Kalle
Kaukinen, Katri
Laurikka, Pilvi
2025

Scandinavian Journal of Gastroenterology
doi:10.1080/00365521.2025.2560000
Näytä kaikki kuvailutiedot
Julkaisun pysyvä osoite on
https://urn.fi/URN:NBN:fi:tuni-2025111910755

Kuvaus

Peer reviewed
Tiivistelmä
Objective: Varying musculoskeletal symptoms, such as joint pain and myalgia, are recognized as possible extraintestinal complaints of coeliac disease (CeD), but little is known about the prevalence and risk factors of these symptoms. In this study the aim was to evaluate the prevalence of and factors associated with self-reported musculoskeletal symptoms among adult CeD patients on a gluten-free diet (GFD). Materials and methods: The presence of current musculoskeletal symptoms was studied in 614 CeD patients on a GFD and 539 of their non-CeD relatives by a systematic interview. The association between musculoskeletal symptoms and various patient-related factors was investigated using logistic regression. Results: CeD patients reported more often current musculoskeletal symptoms than controls (37.8% vs. 22.8%, p < 0.001). CeD was an independent risk factor for musculoskeletal symptoms even after adjusting for age, gender and previously diagnosed co-morbidities, including autoimmune thyroid disease, osteoarthritis and osteoporosis/osteopenia (odds ratio 1.95, 95% confidence interval 1.48–2.59). Factors associated with these symptoms were female sex, higher age at present, long duration of any CeD-related symptoms before diagnosis and presence of autoimmune thyroid diseases and osteoarthritis. Conclusion: CeD is associated with musculoskeletal symptoms even on a strict GFD. Possible susceptibility to current musculoskeletal complaints should be kept in mind, especially among certain risk patients such as those with long diagnostic delay and osteoarthritis.
Kokoelmat
  • TUNICRIS-julkaisut [22389]
Kalevantie 5
PL 617
33014 Tampereen yliopisto
oa[@]tuni.fi | Tietosuoja | Saavutettavuusseloste
 

 

Selaa kokoelmaa

TekijätNimekkeetTiedekunta (2019 -)Tiedekunta (- 2018)Tutkinto-ohjelmat ja opintosuunnatAvainsanatJulkaisuajatKokoelmat

Omat tiedot

Kirjaudu sisäänRekisteröidy
Kalevantie 5
PL 617
33014 Tampereen yliopisto
oa[@]tuni.fi | Tietosuoja | Saavutettavuusseloste